Screening has a central role in colorectal cancer (CRC) control. Different screening tests are
effective in reducing CRC-specific mortality. Influence on cancer incidence depends on test …

Multiple studies have shown that cancer patients produce detectable autoantibodies against
certain tumor-associated antigens, which might be promising blood biomarkers for early …

结直肠癌(colorectal cancer, CRC) 是起源于结直肠黏膜上皮的恶性肿瘤, 是临床最常见的恶性
肿瘤之一. 我国每年结直肠癌新发病例超过25 万, 死亡病例约14 万, 新发和死亡病例均占全世界 …

AIM: To study the epidemiologic indicators of uptake and characteristic colonoscopic
findings in the Croatian National Colorectal Cancer Screening Program. METHODS …

Background This study aimed to investigate the diagnostic value of platelet‐lymphocyte ratio
(PLR) and hemoglobin‐platelet ratio (HPR) combined or not with carcinoembryonic antigen …

内镜诊疗技术因其诊断准确, 创伤小, 恢复快, 已成为临床诊疗工作中不可缺少的重要诊疗手段.
电子胃镜虽然有普通胃镜, 无痛胃镜, 笑气胃镜, 但在诊治舒适度方面, 还是要推崇无痛胃镜 …

Colorectal cancer (CRC) is the second most common malignancy in the western world. Early
detection and diagnosis of all cancer types is vital to improved prognosis by enabling early …

Background: Early diagnosis will significantly improve the survival rate of colorectal cancer
(CRC); however, the existing methods for CRC screening were either invasive or inefficient …

Colorectal cancer (CRC) is the second-most commonly diagnosed cancer worldwide. Early
diagnosis improves prognosis and long-term outcomes. Several studies have found tumor …

Thanks to their specificity and stability in the sera, autoantibodies (AAbs) against tumor-
associated antigens (TAAs) are very attractive biomarkers for the development of less …